Pushing Big Data to Rapidly Advance Patient Care

Technology offers a solution for moving research out of journals and into the clinic faster.

7:47 AM

Author | Kelly Malcom

Big Data

The breakneck pace of biomedical discovery is outstripping clinicians' ability to incorporate this new knowledge into practice. Charles Friedman, Ph.D. and his colleagues recently wrote an article in the Journal of General Internal Medicine about a possible way to approach this problem, one that will accelerate the movement of newly-generated evidence about the management of health and disease into practice that improves the health of patients.

Traditionally, it has taken many years, and even decades, for the knowledge produced from studies to change medical practice. For example, the authors note in the article, the use of clot-busting drugs for the treatment of heart attacks was delayed by as much as 20 years because of this inability to quickly incorporate new evidence.

"There are lots of reasons why new knowledge isn't being rapidly incorporated into practice," says Friedman. "If you have to read it in a journal, understand it, figure out what to do based on it, and fit that process into your busy day and complicated work flow, for a lot of practitioners, there's just not enough room for this."

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Informing medical practice

Much of the generation of new evidence is done by groups like the federal Agency for Healthcare Quality and Research and the Cochrane Collaboration, a UK-based non-profit group designed to organize medical research into systematic reviews and meta analyses. These reviews synthesize all of the available medical research about a given topic with the hope of informing medical practice. However, that movement of this accumulated knowledge to medical practice can happen incredibly slowly, if at all.

The new article focuses on the need to harness the power of technology to enable health systems to analyze the data they generate during the process of taking care of patients to generate new "local" evidence and use this in combination with published reviewed evidence to improve health outcomes.

The value of Big Data is to generate Big Knowledge.
Charles Friedman, Ph.D.

The key to using both types of evidence, they argue, is transforming human readable knowledge--the words, tables and figures in a typical journal article—into computable forms of that same knowledge.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"A lot of scientific studies result in some kind of model: an equation, a guideline, a statistical relationship, or an algorithm. All of these kinds of models can be expressed as computer code that can automatically generate advice about a specific patient," Friedman explains.  When both "local" models and published models are available in computable forms, it is suddenly possible to generate advice that reflects both kinds of sources.

Computable forms are key

He notes that while Michigan Medicine, along with most other health systems that use electronic health records, is using its data to continuously improve quality of care, putting this knowledge in computable forms creates many new ways to apply that knowledge to improve care.

The University of Michigan Medical School's Department of Learning Health Sciences is taking the lead in transforming biomedical knowledge into computable forms that are open and accessible to anyone. They've created a computer platform called the Knowledge Grid, that stores computable knowledge in digital libraries and then uses that knowledge to generate patient-specific advice.

"The value of Big Data is to generate Big Knowledge," says Friedman. "The power of Big Data is to provide better models. If all those models do is sit in journal articles, no one's going to be any healthier."


More Articles About:

Lab Report Basic Science and Laboratory Research Education Future Think Health Care Quality All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.